Evidence map›Paper›PMID 22534961›Full record

ArticleKidney international2012

Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.

Gal Finer, H William Schnaper, Yashpal S Kanwar, Xiaoyan Liang, Herbert Y Lin, Tomoko Hayashida

Open access · greenAbstract read
In one paragraph

Article in Kidney international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gal FinerDivision of Kidney Diseases and Children's Memorial Research Center, Children's Memorial Hospital, Chicago, IL, USA.
H William Schnaper
Yashpal S Kanwar
Xiaoyan Liang
Herbert Y Lin
Tomoko Hayashida
Northwestern University · USHarvard University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Pathogenesis of Diabetic NephropathyR01DK060635 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI QUAGGIN, SUSAN E. · 2002 to 2023
$6.6M
Signaling Pathways in Renal FibrogenesisR01DK049362 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHNAPER, H WILLIAM · 1994 to 2014
$4.0M
Regulation of BMP Signaling in the KidneyR01DK069533 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LIN, HERBERT Y · 2005 to 2014
$3.3M
Mechanisms of Action of HemojuvelinR01DK071837 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LIN, HERBERT Y · 2005 to 2014
$3.3M
Adaptor Molecules in TGF-beta SignalingR01DK075663 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHNAPER, H WILLIAM · 2008 to 2012
$1.5M
NCI NIH HHS P30 CA060553NIDDK NIH HHS R01 DK049362NIDDK NIH HHS R01-DK049362NIDDK NIH HHS R01 DK060635NIDDK NIH HHS R01-DK060635NIDDK NIH HHS R01 DK069533NIDDK NIH HHS R01-DK069533NIDDK NIH HHS R01 DK071837NIDDK NIH HHS R01-DK071837NIDDK NIH HHS R01 DK075663NIDDK NIH HHS R01-DK075663
6 · The paper itself

Abstract

Multiple transforming growth factor (TGF)-β-induced fibrogenic signals have been described in vitro. To evaluate mechanisms in vivo, we used an adriamycin nephropathy model in 129x1/Svj mice that display massive proteinuria by days 5 to 7 and pathological findings similar to human focal segmental glomerulosclerosis by day 14. TGF-β mRNA expression increased after day 7 along with nuclear translocation of the TGF-β receptor-specific transcription factor Smad3. Inhibiting TGF-β prevented both pathological changes and type-I collagen and fibronectin mRNA expression, but proteinuria persisted. Renal Akt was phosphorylated in adriamycin-treated mice, suggesting PI3-kinase activation. Expression of mRNA for the p110γ isozyme of PI3-kinase was specifically increased and p110γ colocalized with nephrin by immunohistochemistry early in disease. Nephrin levels subsequently decreased. Inhibition of p110γ by AS605240 preserved nephrin expression and prevented proteinuria. In cultured podocytes, adriamycin stimulated p110γ expression. AS605240, but not a TGF-β receptor kinase inhibitor, prevented adriamycin-induced cytoskeletal disorganization and apoptosis, supporting a role for p110γ in podocyte injury. AS605240, at a dose that decreased proteinuria, prevented renal collagen mRNA expression in vivo but did not affect TGF-β-stimulated collagen induction in vitro. Thus, PI3-kinase p110γ mediates initial podocyte injury and proteinuria, both of which precede TGF-β-mediated glomerular scarring.

Indexed as

DoxorubicinSignal TransductionAnimalsApoptosisCells, CulturedClass I Phosphatidylinositol 3-KinasesCollagen Type IDisease Models, AnimalFibronectinsFibrosisGlomerulosclerosis, Focal SegmentalImmunohistochemistryKidneyMaleMembrane ProteinsMice1-phosphatidylinositol 3-kinase p110 subunit, mouseClass I Phosphatidylinositol 3-KinasesCollagen Type IDoxorubicinFibronectinsMembrane ProteinsnephrinProtein Kinase InhibitorsProto-Oncogene Proteins c-aktReceptors, Transforming Growth Factor betaRNA, MessengerSmad3 ProteinSmad3 protein, mouseTransforming Growth Factor beta

Identifiers

PMID22534961
PMCPMC3425729
OpenAlexW2110828351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.